Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
NCT05151848
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Takayasu Arteritis
Interventions
DRUG:
Adalimumab Injection
DRUG:
Tofacitinib 5 MG
Sponsor
Chinese SLE Treatment And Research Group